What does CUSIP 501575104 represent in this 13F holders report?

CUSIP 501575104 is the security identifier for KYMR - Kymera Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held KYMR - Kymera Therapeutics, Inc. - Common Stock in Q4 2021?

123 institutional investors reported KYMR - Kymera Therapeutics, Inc. - Common Stock for Q4 2021. Use the holders table for investor-level position and value details.

Kymera Therapeutics, Inc. - Common Stock (KYMR)

CUSIP: 501575104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock
Shares outstanding: 80,235,145
Total 13F shares: 43,015,870
Share change: +1,981,264
Total reported value: $2,729,867,438
Put/Call ratio: 3.1%
Price per share: $63.49
Number of holders: 123
Value change: +$128,644,677
Number of buys: 73
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 501575104?
CUSIP 501575104 identifies KYMR - Kymera Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 501575104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KYMR - Kymera Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4%	3,233,197	$189,918,000	—	30 Sep 2021	13F
BVF INC/IL	13F	Company	4%	3,180,658	$186,832,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	3.8%	3,040,431	$178,595,000	—	30 Sep 2021	13F
ATLAS VENTURE ASSOCIATES X, L.P.	3/4/5	10%+ Owner	— class O/S missing	5,763,012	$173,161,222	—	11 Aug 2021	3/4/5
VANGUARD GROUP INC	13F	Company	3.6%	2,901,574	$170,438,000	—	30 Sep 2021	13F
Redmile Group, LLC	13F	Company	3.5%	2,793,708	$164,102,000	—	30 Sep 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.1%	2,467,935	$144,966,000	—	30 Sep 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	3%	2,384,742	$140,080,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	2.9%	2,355,807	$138,380,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.8%	1,439,776	$84,572,000	—	30 Sep 2021	13F
Rock Springs Capital Management LP	13F	Company	0.91%	732,927	$43,052,000	—	30 Sep 2021	13F
AJU IB Investment Co., Ltd.	13F	Company	0.8%	639,059	$37,538,000	—	30 Sep 2021	13F
Deer IX & Co. Ltd.	13F	Company	0.77%	615,895	$36,178,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.75%	599,870	$35,236,000	—	30 Sep 2021	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.73%	583,192	$34,257,000	—	30 Sep 2021	13F
Avidity Partners Management LP	13F	Company	0.64%	514,500	$30,222,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.62%	500,880	$29,422,000	—	30 Sep 2021	13F
Avoro Capital Advisors LLC	13F	Company	0.57%	455,750	$26,771,000	—	30 Sep 2021	13F
Artal Group S.A.	13F	Company	0.5%	400,000	$23,496,000	—	30 Sep 2021	13F
S.c.a. Candriam	13F	Individual	0.49%	394,991	$23,201,000	—	30 Sep 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.45%	359,260	$21,103,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.42%	338,723	$19,897,000	—	30 Sep 2021	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.34%	271,000	$15,919,000	—	30 Sep 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.33%	266,289	$15,641,817	—	30 Sep 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.31%	250,000	$14,685,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.3%	243,225	$14,288,000	—	30 Sep 2021	13F
WASATCH ADVISORS LP	13F	Company	0.3%	241,366	$14,178,000	—	30 Sep 2021	13F
JENNISON ASSOCIATES LLC	13F	Company	0.23%	184,581	$10,842,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	180,207	$10,585,000	—	30 Sep 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.22%	180,000	$10,573,000	—	30 Sep 2021	13F
BANK OF MONTREAL /CAN/	13F	Company	0.22%	174,026	$10,219,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.21%	165,935	$9,746,000	—	30 Sep 2021	13F
Point72 Asset Management, L.P.	13F	Company	0.2%	157,400	$9,246,000	—	30 Sep 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.19%	150,746	$8,855,000	—	30 Sep 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.16%	131,694	$7,736,000	—	30 Sep 2021	13F
Woodline Partners LP	13F	Company	0.16%	129,331	$7,597,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.15%	116,961	$7,363,000	—	30 Sep 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.16%	125,000	$7,343,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.14%	113,928	$6,692,000	—	30 Sep 2021	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.12%	93,049	$5,466,000	—	30 Sep 2021	13F
Asymmetry Capital Management, L.P.	13F	Company	0.11%	89,071	$5,232,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.11%	87,556	$5,142,000	—	30 Sep 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.08%	67,965	$3,992,000	—	30 Sep 2021	13F
LMR Partners LLP	13F	Company	0.08%	65,941	$3,873,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.08%	60,500	$3,554,000	—	30 Sep 2021	13F
NATIXIS	13F	Company	0.07%	56,139	$3,298,000	—	30 Sep 2021	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.07%	54,574	$3,206,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.07%	54,163	$3,182,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.07%	53,338	$3,133,000	—	30 Sep 2021	13F
Laurion Capital Management LP	13F	Company	0.06%	48,987	$2,877,000	—	30 Sep 2021	13F

Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q4 2021

As of 31 Dec 2021, Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by 123 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,015,870 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., BVF INC/IL, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, BAKER BROS. ADVISORS LP, FMR LLC, and STATE STREET CORP. This page lists 124 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

115

Q4 2021 holders

123

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.